Applied Therapeutics, Inc. — Director's Dealing 2019

May 14, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2019-05-13

Reporting Person: Shendelman Shoshana (Director, President and CEO, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3480662	Direct
Common Stock	1270717	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$1.00	2017-03-27	Common Stock (27624)		Direct
Employee Stock Option (right to buy)	$1.44	2028-03-07	Common Stock (726961)		Direct
Employee Stock Option (right to buy)	$4.70	2029-03-17	Common Stock (948894)		Direct

Footnotes

F1: These options became fully vested on April 22, 2019.

F2: One-third (1/3rd) of the shares subject to the option vested or shall vest on March 8, 2018, March 8, 2019 and March 8, 2020, subject to the Reporting Person continuing to provide service through each such date.

F3: One-third (1/3rd) of the shares subject to the option vested or shall vest on each of March 18, 2019, March 18, 2020 and March 8, 2021, subject to the Reporting Person continuing to provide service through each such date.